Category: Anaemic Hypoxia

DUBLIN–(BUSINESS WIRE[1])–The “Iron Deficiency Anemia Pipeline Research Monitor, 2020 – Drugs, Companies, Clinical Trials, R&D Pipeline Updates, Status and Outlook”[2] report has been added to ResearchAndMarkets.com’s offering. PIPELINE HIGHLIGHTS Iron Deficiency Anemia is one of the widely researched conditions during 2020 with 13 companies actively focusing on realizing pipeline’s potential. Development of Iron Deficiency Anemia medicines is identified as integral...

MORRISTOWN, N.J., Feb. 10, 2020 /PRNewswire/ — Pharmacosmos Therapeutics Inc. announced today that it has been established as a newly formed specialty pharmaceutical company dedicated to commercializing Monoferric® for Iron Deficiency Anemia (IDA) patients in the US. The new company is a subsidiary of the Pharmacosmos Group, a profitable, fast-growing specialty pharmaceutical company headquartered in Denmark. Monoferric® is an intravenous...

MANHASSET, N.Y.–(BUSINESS WIRE[1])–Nearly 1.6 billion people worldwide suffer from anemia, and for the first time new research points to how resistance emerges to the drug dexamethasone used to treat the devastating inherited form of anemia known as Diamond Blackfan anemia (DBA). The Feinstein Institutes for Medical Research[2] professor and expert in disorders of the red cell Lionel Blanc, PhD,[3] published...

Abstract Oxygen must be transported effectively from the atmosphere to the tissues in order to sustain normal metabolism. An understanding of oxygen delivery is therefore central to the management of patients during anaesthesia, resuscitation and during critical illness. This review deals specifically with the transport of oxygen from the lungs to non-pulmonary tissues. Key points Oxygen is carried in arterial...